ArticleCancer medicine2026
Predicting Postoperative Survival in Patients With Malignant Biliary Obstruction Using an Interpretable Machine Learning Model: A Multicenter Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic bile duct drainage is crucial for improving the survival and quality of life in patients with malignant biliary obstruction (MBO). This study aimed to identify key factors that affect postoperative survival in patients with MBO, develop a predictive model, and validate the performance of the model using external data.
methodsData were retrospectively collected from The First Hospital of Jiaxing (between 2013 and 2021), The Second Hospital of Jiaxing (between 2014 and 2021), and Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine (between 2014 and 2021). Patient demographics, disease characteristics, and laboratory results of 337 patients were analyzed. Various machine learning models, including the gradient boosted survival tree, extreme gradient boosting (XGBoost), XGBoost accelerated failure time (XGBoost AFT), random survival forests, and Cox proportional hazards regression, were used. The model performance was assessed using the concordance index (C-index), and SHapley Additive exPlanations (SHAP) values were used to interpret the model.
resultsThe XGBoost AFT model exhibited the best performance, with C-index values of 0.902, 0.722, and 0.705 for the training cohort, test cohort 1, and test cohort 2, respectively. The SHAP analysis revealed that distant metastasis, high total bilirubin level, prolonged prothrombin time, and high-level obstruction significantly impacted survival. A Kaplan-Meier survival analysis demonstrated that the model effectively stratified patients into the high-risk and low-risk groups.
conclusionsThis study provides a robust model that can predict the postoperative survival in patients with MBO. This model was validated using external data, and the results offer valuable guidance for postoperative management and personalized treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.